| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/28/2006 | US7019067 Polymer powders, pressure sensitive adhesives and methods of making the same |
| 03/28/2006 | US7018980 Dissolving drug in acidic aqueous buffered solution; adding surfactant and oil; agitation; oral administering |
| 03/28/2006 | US7018825 DNase liquid solutions |
| 03/28/2006 | US7018819 Method and apparatus for manipulation of cells and cell-like structures focused electric fields in microfludic systems and use thereof |
| 03/28/2006 | US7018662 Palliative effects of morinda citrifolia oil and juice |
| 03/28/2006 | US7018658 Pharmaceutical pellets comprising tamsulosin |
| 03/28/2006 | US7018657 Nanoparticles incorporated in an aerosol composition suitable for deep lung delivery by means of metered dose inhaler; drug delivery |
| 03/28/2006 | US7018656 Gel formulations of 1-hydroxy-2(H)pyridone derivatives, which contain solvents and hydrophilic gel-forming agents |
| 03/28/2006 | US7018655 Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions |
| 03/28/2006 | US7018654 Pharmaceutical composition containing an active agent in an amino acid copolymer structure |
| 03/28/2006 | US7018653 Method for preparing solid dosage form of desmopressin |
| 03/28/2006 | US7018652 Composition and method for treating nonalcoholic steatohepatitis |
| 03/28/2006 | US7018651 Inert core particles coated with a carbohydrate matrix encapsulating an active compound, e.g., flavors, perfumes, drugs and wash-active components; shelf life; protective coatings; drug delivery; reconstitutional beverage premixes |
| 03/28/2006 | US7018649 Felodipine transdermal device and methods |
| 03/28/2006 | US7018648 Transdermal device for administering testosterone or one of the derivatives thereof |
| 03/28/2006 | US7018647 Patches for external use |
| 03/28/2006 | US7018645 biodegradable and water soluble polyesterether block polymers used for drug delivery |
| 03/28/2006 | US7018635 Semi-refined carrageenan |
| 03/28/2006 | US7018630 administering subtilisins obtained from grampositive bacterial residues that vitamin k2 has been removed using chitosan |
| 03/28/2006 | US7018622 Packaged product for use with tooth whitening systems that is storage stable in absence of light |
| 03/28/2006 | US7018621 dosage form serotonin agonists comprising aerosols formed by heating layers of the drugs on solid supports, to form vapors, then condensing to form condensates which can be administered by breathing; prophylaxis of headaches |
| 03/28/2006 | US7018620 Delivery of beta-blockers through an inhalation route |
| 03/28/2006 | US7018619 Administering a therapeutic amount of an alprazolam, estazolam, midazolam or triazolam condensation aerosol for therapy of anxiety or insomnia |
| 03/28/2006 | US7018618 An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter of |
| 03/28/2006 | US7018613 Preparations for evaluating eliminative ability of stomach |
| 03/28/2006 | US7018609 For drug delivery |
| 03/28/2006 | US7018419 Carrier for pancreatic cells for transplantation into an animal body is formed with a lateral extent much greater than its thickness to enhance its diffusional capability; enhanced hormonal response to stimuli as in blood sugar levels |
| 03/28/2006 | US7018395 to destroy or impair target cells expressing a vascular endothelial growth factor (VEGF) receptor by administering a liposome system of conjugated antibodies, conjugated photosensitizer and another liposome conjugate and using light of an intensity such that nontarget cells are not destroyed |
| 03/28/2006 | US7018375 Drug delivery device |
| 03/28/2006 | US7018365 Threaded syringe with quick stop |
| 03/28/2006 | US7017573 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 03/28/2006 | US7017388 Determination of gas-free densities and relative amounts of gases in liquids in manufacturing processes |
| 03/28/2006 | CA2278744C Continuous microsphere process |
| 03/28/2006 | CA2208541C The production of covered tablets |
| 03/23/2006 | WO2006032043A2 Lubricious compounds for biomedical applications using hydrophilic polymers |
| 03/23/2006 | WO2006032018A2 Highly-aqueous non-respirable aerosols containing biologically-active ingredients method of making and device therefor |
| 03/23/2006 | WO2006031857A2 Delivering iron to an animal |
| 03/23/2006 | WO2006031856A2 Biosynchronous transdermal drug delivery |
| 03/23/2006 | WO2006031848A2 Corticosteroid topical dispersion with low content of surfactant |
| 03/23/2006 | WO2006031787A2 Low-obscuration image transmitting particulate ocular therapeutic formulations |
| 03/23/2006 | WO2006031658A2 Therapeutic lacrimal canalicular inserts and related methods |
| 03/23/2006 | WO2006031584A2 Quick dissolve medicament and method of manufacturing |
| 03/23/2006 | WO2006031471A2 Liposomal vectors |
| 03/23/2006 | WO2006031420A2 Multi-layer tablets and bioadhesive dosage forms |
| 03/23/2006 | WO2006031391A2 Method and device for the delivery of a substance including a covering |
| 03/23/2006 | WO2006031271A2 Pharmaceutically elegant, topical anhydrous aerosol foam |
| 03/23/2006 | WO2006031256A1 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| 03/23/2006 | WO2006031191A1 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 03/23/2006 | WO2006031142A1 Biologically active material, method for the production thereof and a therapeutic agent based thereon |
| 03/23/2006 | WO2006030851A1 Pirenoxine suspension type eye lotion |
| 03/23/2006 | WO2006030850A1 Method of preparing solution of lipid-soluble ingredient |
| 03/23/2006 | WO2006030450A2 Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy |
| 03/23/2006 | WO2006030431A2 Biocompatible drug delivery apparatus and methods |
| 03/23/2006 | WO2006030402A2 Dual compartment osmotic delivery device |
| 03/23/2006 | WO2006030303A1 Oral extended release dosage form comprising a high dose biguanide and a low dose sulfonylurea |
| 03/23/2006 | WO2006030301A1 Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers |
| 03/23/2006 | WO2006030297A1 Taste masked granules comprising clarithromycin, hydrocolloids and a coating |
| 03/23/2006 | WO2006030194A1 Substance delivery device |
| 03/23/2006 | WO2006030112A1 Method for coating powders |
| 03/23/2006 | WO2006030111A2 Biodegradable polymer microparticles |
| 03/23/2006 | WO2006030030A2 System for the sequential, transdermal administration of systemically active substances |
| 03/23/2006 | WO2006029845A2 Delivery vehicle containing nanoparticles |
| 03/23/2006 | WO2006029740A2 Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer |
| 03/23/2006 | WO2006029726A1 Dermally applicable formulations for treating skin diseases in animals |
| 03/23/2006 | WO2006029554A1 Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation |
| 03/23/2006 | WO2006002326A3 Methods for treatment of wounds using time release compositions |
| 03/23/2006 | WO2005094790A8 Liposomal formulations |
| 03/23/2006 | WO2005094785A3 Compositions capable of facilitating penetration across a biological barrier |
| 03/23/2006 | WO2005086915A3 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor |
| 03/23/2006 | WO2005079749A3 Chitosan containing solution |
| 03/23/2006 | WO2005079284A3 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 03/23/2006 | WO2005077337A3 Dispersions prepared by use of self-stabilizing agents |
| 03/23/2006 | WO2005053639A3 Controlled release multiparticulates formed with dissolution enhancers |
| 03/23/2006 | WO2005048985A3 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 03/23/2006 | WO2005044187A3 Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| 03/23/2006 | WO2004110585A9 Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product |
| 03/23/2006 | WO2004064772A3 Methods and dosage forms with modified viscosity layers |
| 03/23/2006 | US20060064068 body fluids, such as urine, feces, menses; comprises a skin conditioning agent, a viscosity enhancing agent and an oleophilic film-forming agent; applied to the skin by suitable delivery vehicles, such as absorbent articles or components thereof, sheet materials, pads, bandages, sponges, foam pads, pumps |
| 03/23/2006 | US20060063883 Indicator devices and articles comprising the indicator device |
| 03/23/2006 | US20060063882 Dissolving polymer (polyethers; polyamides; polyamideimides; polysaccharides; epoxy resins) in solvent, adding to miscible solvent dispersion forming drops, introducing shear stress to elongate the droplets to form microrods, then solidifying by attrition of solvent |
| 03/23/2006 | US20060063840 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 03/23/2006 | US20060063832 Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
| 03/23/2006 | US20060063781 Pharmaceutical composition for regeneration of cirrhotic liver |
| 03/23/2006 | US20060063753 Use of nefopam for the treatment of nausea or emesis |
| 03/23/2006 | US20060063732 Compositions and methods for gene therapy |
| 03/23/2006 | US20060063714 Liquid, aqueous, pharmaceutical compositions of factor VII polypeptides |
| 03/23/2006 | US20060063706 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals; treating infection caused by methicillin-resistant Staphylococcus aureus |
| 03/23/2006 | US20060062860 Use of anemonin for treating aseptic inflammations |
| 03/23/2006 | US20060062856 Controlled release galantamine composition |
| 03/23/2006 | US20060062855 Therapeutic calcium phosphate particles for use in inhibiting expression of a gene |
| 03/23/2006 | US20060062854 Hydrogel having anti-microbial properties |
| 03/23/2006 | US20060062853 Treating neuromuscular disorders with an oral formulation of creatine derivatives |
| 03/23/2006 | US20060062851 Delivery device containing venlafaxine and memantine and methods of use thereof |
| 03/23/2006 | US20060062850 Controlled release antimicrobial polymer compositions |
| 03/23/2006 | US20060062849 Oral formulation of creatine derivatives and method of manufacturing same |
| 03/23/2006 | US20060062848 Formulation comprising itraconazole |
| 03/23/2006 | US20060062847 Pharmaceutical dosage forms with impeded extractability of a sympathomimetic |
| 03/23/2006 | US20060062846 Alfuzosin tablets and synthesis |
| 03/23/2006 | US20060062845 Alfuzosin tablets and synthesis |
| 03/23/2006 | US20060062844 Taste-masking coated particles, process for the preparation thereof and orodispersible tablets containing said coated particles |